Corporate investors have become pivotal players in VC markets around the globe, able to move markets. It’s now time to press our advantage.

Hospital CVCs are growing and diversifying to confront the challenges facing the US healthcare system.

Some 37 corporate-backed startups were bought in February in sectors ranging from semiconductors and skincare to pharma and robots.

Medtech funding has been one of the fastest growing areas of CVC, and here are some of its brightest startups, from brain surgery microbots to holographic surgery technology.

The venture firm is targeting consumer health startups that can prevent illness before it happens and has secured health product maker Schwabe as its financier.

January 2025 saw 53 corporate-backed startup exits, marking a 47% year-on-year increase and the highest total since early 2023, with deal values soaring to $4.52bn.

Clinics offering wraparound care for people taking weight loss drugs have become high-growth businesses, attractive to investors.

Its reputation of political neutrality — and strength in life sciences — is making Singapore a favoured launchpad for western investors and Chinese startups.

The fund will be managed by the US venture capital firm's healthcare team.

Providence will be an anchor investor in the newly independent venture capital firm, Allumia Ventures.